Revvity Total Liabilities and Share Holders Equity 2010-2025 | RVTY
Revvity total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Revvity total liabilities and share holders equity for the quarter ending March 31, 2025 was $12.361B, a 7.98% decline year-over-year.
- Revvity total liabilities and share holders equity for 2024 was $12.392B, a 8.64% decline from 2023.
- Revvity total liabilities and share holders equity for 2023 was $13.565B, a 4% decline from 2022.
- Revvity total liabilities and share holders equity for 2022 was $14.13B, a 5.8% decline from 2021.
| Revvity Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $12,392 |
| 2023 | $13,565 |
| 2022 | $14,130 |
| 2021 | $15,001 |
| 2020 | $7,960 |
| 2019 | $6,539 |
| 2018 | $5,976 |
| 2017 | $6,091 |
| 2016 | $4,277 |
| 2015 | $4,166 |
| 2014 | $4,128 |
| 2013 | $3,947 |
| 2012 | $3,902 |
| 2011 | $3,856 |
| 2010 | $3,209 |
| 2009 | $3,059 |
| Revvity Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $12,361 |
| 2024-12-31 | $12,392 |
| 2024-09-30 | $12,770 |
| 2024-06-30 | $13,425 |
| 2024-03-31 | $13,433 |
| 2023-12-31 | $13,565 |
| 2023-09-30 | $13,422 |
| 2023-06-30 | $14,219 |
| 2023-03-31 | $14,638 |
| 2022-12-31 | $14,130 |
| 2022-09-30 | $13,824 |
| 2022-06-30 | $14,190 |
| 2022-03-31 | $14,848 |
| 2021-12-31 | $15,001 |
| 2021-09-30 | $14,900 |
| 2021-06-30 | $8,739 |
| 2021-03-31 | $8,763 |
| 2020-12-31 | $7,960 |
| 2020-09-30 | $6,866 |
| 2020-06-30 | $6,637 |
| 2020-03-31 | $6,384 |
| 2019-12-31 | $6,539 |
| 2019-09-30 | $6,489 |
| 2019-06-30 | $6,399 |
| 2019-03-31 | $6,086 |
| 2018-12-31 | $5,976 |
| 2018-09-30 | $5,862 |
| 2018-06-30 | $5,958 |
| 2018-03-31 | $6,126 |
| 2017-12-31 | $6,091 |
| 2017-09-30 | $4,739 |
| 2017-06-30 | $4,605 |
| 2017-03-31 | $4,341 |
| 2016-12-31 | $4,277 |
| 2016-09-30 | $4,305 |
| 2016-06-30 | $4,194 |
| 2016-03-31 | $4,211 |
| 2015-12-31 | $4,166 |
| 2015-09-30 | $4,032 |
| 2015-06-30 | $4,083 |
| 2015-03-31 | $4,028 |
| 2014-12-31 | $4,128 |
| 2014-09-30 | $3,886 |
| 2014-06-30 | $3,937 |
| 2014-03-31 | $3,971 |
| 2013-12-31 | $3,947 |
| 2013-09-30 | $3,852 |
| 2013-06-30 | $3,811 |
| 2013-03-31 | $3,808 |
| 2012-12-31 | $3,902 |
| 2012-09-30 | $3,890 |
| 2012-06-30 | $3,801 |
| 2012-03-31 | $3,864 |
| 2011-12-31 | $3,856 |
| 2011-09-30 | $3,402 |
| 2011-06-30 | $3,596 |
| 2011-03-31 | $3,306 |
| 2010-12-31 | $3,209 |
| 2010-09-30 | $3,248 |
| 2010-06-30 | $3,146 |
| 2010-03-31 | $3,027 |
| 2009-12-31 | $3,059 |
| 2009-09-30 | $3,059 |
| 2009-06-30 | $2,946 |
| 2009-03-31 | $2,858 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.722B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.699B | 26.28 |
| CVS Health (CVS) | United States | $78.241B | 9.72 |
| Elevance Health (ELV) | United States | $66.788B | 8.98 |
| Cencora (COR) | United States | $56.876B | 19.79 |
| DiDi Global (DIDIY) | China | $27.957B | 29.70 |
| Labcorp Holdings (LH) | United States | $20.968B | 17.01 |
| Natera (NTRA) | United States | $18.819B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.728B | 0.00 |
| ICON (ICLR) | Ireland | $13.558B | 13.05 |
| CochLear (CHEOY) | Australia | $13.493B | 0.00 |
| Solventum (SOLV) | United States | $12.872B | 13.63 |
| Medpace Holdings (MEDP) | United States | $12.288B | 32.52 |
| Viatris (VTRS) | United States | $10.997B | 3.78 |
| Avantor (AVTR) | United States | $9.267B | 13.47 |
| Sonic Healthcare (SKHHY) | Australia | $9.129B | 0.00 |
| HealthEquity (HQY) | United States | $8.380B | 36.71 |
| Charles River Laboratories (CRL) | United States | $8.249B | 16.17 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.640B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.038B | 29.67 |
| BrightSpring Health Services (BTSG) | United States | $3.745B | 34.35 |
| Sotera Health (SHC) | United States | $3.364B | 19.11 |
| Surgery Partners (SGRY) | United States | $2.848B | 37.03 |
| Organon (OGN) | United States | $2.626B | 2.79 |
| Concentras Parent (CON) | United States | $2.584B | 14.93 |
| Alignment Healthcare (ALHC) | United States | $2.453B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.367B | 91.15 |
| Progyny (PGNY) | United States | $2.011B | 44.26 |
| PACS (PACS) | United States | $1.821B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.800B | 36.00 |
| Premier (PINC) | United States | $1.761B | 13.37 |
| Ardent Health (ARDT) | United States | $1.582B | 6.74 |
| Teladoc Health (TDOC) | United States | $1.505B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.249B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.126B | 8.57 |
| QDM (QDMI) | Hong Kong, SAR China | $0.999B | 342.50 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.786B | 7.35 |
| CareDx (CDNA) | United States | $0.731B | 11.41 |
| Embecta (EMBC) | United States | $0.680B | 4.58 |
| So-Young (SY) | China | $0.557B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.540B | 0.00 |
| Nutex Health (NUTX) | United States | $0.516B | 7.81 |
| SBC Medicals (SBC) | United States | $0.510B | 0.00 |
| Omada Health (OMDA) | $0.496B | 0.00 | |
| LifeMD (LFMD) | United States | $0.493B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.432B | 0.00 |
| Enhabit (EHAB) | United States | $0.350B | 28.83 |
| Oncology Institute (TOI) | United States | $0.331B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.295B | 0.00 |
| Beauty Health (SKIN) | United States | $0.255B | 0.00 |
| DocGo (DCGO) | United States | $0.159B | 26.00 |
| Pheton Holdings (PTHL) | China | $0.155B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.117B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |